NCT05868044View on ClinicalTrials.gov

REsponse to Combined SONS and ONS in Chronic Cluster HeadachE

NAActive, not recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

April 23, 2024

Study Completion Date

April 30, 2026

Conditions
Chronic Cluster Headache
Interventions
DEVICE

PRIMUS

PRIMUS system

Trial Locations (1)

4556

Resolve Pain, Buderim

Sponsors
All Listed Sponsors
lead

Salvia BioElectronics

INDUSTRY

NCT05868044 - REsponse to Combined SONS and ONS in Chronic Cluster HeadachE | Biotech Hunter | Biotech Hunter